The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Letters to the Editor

Letters to the Editor

January 1, 2008 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In “Know Your Unknown Unknowns,” (October 2007 TR, p. 6), we asked for your thoughts on whether or not to administer steroids post-surgery for a woman with giant cell arteritis (GCA) of the aorta. (See patient description below). We’ve published a selection of those responses here, and we want to thank everyone who wrote in. Keep those letters coming!—The Editors

You Might Also Like
  • Letters to the Editor
  • Letters: Don’t Forget Lyme Disease When Considering Polymyalgia Rheumatica
  • Know Your Unknown Unknowns
Explore This Issue
January 2008
Also By This Author
  • Annual REF 5K Run/Walk to Take Place in Boston

Mixed Views on Steroid Use

No doubt that steroids were needed in this case. The key question: Were the margins of the graft involved or free of giant cell inflammation? If the inflammatory process was extensive at the graft-tissue interface, I would be concerned about healing at the interface. If the interface was clear and the patient would be followed closely for amaurosis or other ominous symptoms, then I would be more likely to be patient on starting steroids. Do no harm.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The Patient

  • Woman in her 70s with age-related medical conditions and ill-defined chest pain;
  • Aneurysm of the ascending thoracic aorta treated surgically with a graft; and
  • Pathologically diagnosed GCA of the aorta.

Now the question is how long does it take normally for an aortic graft-tissue interface to heal in a 70-year-old patient? We now know that atherosclerosis is an inflammatory process and that many of these grafts will go into an area of inflammatory atheromatous aorta—at times flagrantly inflamed. Yet from what I gather they usually heal. This patient may have had both giant cell aortitis and inflammatory atherosclerosis.

My guess is that steroids were held, the graft healed, and steroids were started later with no end point to follow. A PET scan can show active inflammation in giant cell aortitis and smaller arteries and may provide some additional information about extent and activity.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Robert Thoburn, MD,
adjunct clinical assistant professor of rheumatology,
University of Florida College of Medicine,
Gainesville

 

I hate to say that the surgeon is probably right and the rheumatologist wrong in this case. Why? The vasculitis (of the aorta) was found by accident (vague abdominal pains). No other stigmata of vasculitis whatsoever were found on physical or imaging examination. This was probably an isolated vasculitis of the aorta.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Therefore—although this sounds a bit weird—surgery could have cured her vasculitis, and steroids can be withheld.

On the other hand, if there were other symptoms, such as headache or blurred vision, or stigmata like elevated erythrocyte sedimentation rate (ESR) (which she did not have, we were told), then we’d have cause to seriously consider systemic therapy.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions Tagged With: aorta, atherosclerosis, giant cell arteritis (GCA), inflammation, Letters, SteroidsIssue: January 2008

You Might Also Like:
  • Letters to the Editor
  • Letters: Don’t Forget Lyme Disease When Considering Polymyalgia Rheumatica
  • Know Your Unknown Unknowns
  • Letters to the Editor

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.